Soluble PD-L1 levels correlate with efficacy of PD-1/PD-L1 inhibitors in lung cancer

被引：0
|
作者：
Kang, Da Hyun [1 ]
Koh, Jeong Suk [1 ]
Chung, Chaeuk [1 ]
Park, Dongil [1 ]
Lee, Song-I [1 ]
Lee, Jeong Eun [1 ]
机构：
[1] Chungnam Natl Univ, Internal Med, Daejeon, South Korea
来源：
RESPIROLOGY | 2023年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
AO17-3
引用
收藏
页码：99 / 99
页数：1
相关论文
共 50 条
  • [1] PD-L1 expression and PD-1/PD-L1 inhibitors in breast cancer
    Monneur, Audrey
    Goncalves, Anthony
    Bertucci, Francois
    [J]. BULLETIN DU CANCER, 2018, 105 (03) : 261 - 272
  • [2] PD-1/PD-L1 inhibitors
    Sunshine, Joel
    Taube, Janis M.
    [J]. CURRENT OPINION IN PHARMACOLOGY, 2015, 23 : 32 - 38
  • [3] The clinical significance of soluble PD-1 and PD-L1 in lung cancer
    Abu Hejleh, Taher
    Furqan, Muhammad
    Ballas, Zuhair
    Clamon, Gerald
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2019, 143 : 148 - 152
  • [4] Efficacy of PD-1 or PD-L1 inhibitors and PD-L1 expression status in cancer: meta-analysis
    Shen, Xian
    Zhao, Bin
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2018, 362
  • [5] PD-1/PD-L1 Inhibitors in Cervical Cancer
    Liu, Yuncong
    Wu, Li
    Tong, Ruizhan
    Yang, Feiyue
    Yin, Limei
    Li, Mengqian
    You, Liting
    Xue, Jianxin
    Lu, You
    [J]. FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [6] PD-1/PD-L1 Axis in Lung Cancer
    Santini, Fernando C.
    Hellmann, Matthew D.
    [J]. CANCER JOURNAL, 2018, 24 (01): : 15 - 19
  • [7] Efficacy of PD-1/PD-L1 immune checkpoint inhibitors and PD-L1 testing in thoracic cancers
    Duruisseaux, Michael
    Rouquette, Isabelle
    Adam, Julien
    Cortot, Alexis
    Cazes, Aurelie
    Gibault, Laure
    Damotte, Diane
    Lantuejoul, Sylvie
    [J]. ANNALES DE PATHOLOGIE, 2017, 37 (01) : 61 - 78
  • [8] Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors
    Ming Yi
    Dechao Jiao
    Hanxiao Xu
    Qian Liu
    Weiheng Zhao
    Xinwei Han
    Kongming Wu
    [J]. Molecular Cancer, 17
  • [9] Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors
    Yi, Ming
    Jiao, Dechao
    Xu, Hanxiao
    Liu, Qian
    Zhao, Weiheng
    Han, Xinwei
    Wu, Kongming
    [J]. MOLECULAR CANCER, 2018, 17
  • [10] Biological Characteristics and Clinical Significance of Soluble PD-1/PD-L1 and Exosomal PD-L1 in Cancer
    Niu, Mengke
    Liu, Yiming
    Yi, Ming
    Jiao, Dechao
    Wu, Kongming
    [J]. FRONTIERS IN IMMUNOLOGY, 2022, 13
12345